Current stock page

Stock Analysis

Fortrea Holdings Inc. (FTRE) Stock Analysis

Fortrea Holdings Inc. (FTRE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

FTRE Stock Analysis Summary

Fortrea Holdings Inc. (FTRE) currently has an AIQ Score of 75/100, indicating a bullish setup. Value is the strongest factor at 93/100. Risk is the weakest current factor at 41/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

FTRE at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$20.20
AIQ Score75/100
Overall ViewBullish
Technical Analysis ConsensusSell
Market Cap$1.93B
P/E Ratio (TTM)-26.8
Forward P/E—
EPS (Q3 FY2026)$0.01
Revenue (Q3 FY2026)$691.5M
Dividend Yield (TTM)0.00%
Beta1.62
Volume1.96M
52-week range$8.55-$26.16
RSI 1443.47
50-Day SMA$20.76
200-Day SMA$15.90
Analyst Price Target$24.75
Next EarningsFeb 25, 2027
As of Nov 13, 2026 · Market close

FTREFortrea Holdings Inc.

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 9/10
$20.20+$0.14 (+0.70%)

Latest quote

  • Momentum
    88
  • Value
    93
  • Quality
    65
  • Risk resilience
    41
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

FTRE Stock Analysis Summary

Fortrea Holdings Inc. (FTRE) currently has an AIQ Score of 75/100, indicating a bullish setup. Value is the strongest factor at 93/100. Risk resilience is the weakest current factor at 41/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, FTRE has AIQ Score of 75/100 with Value base of 93/100 and fading Risk resilience at 41/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Value (93/100) leads while Risk resilience (41/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 0.70% stock move · FTRE classified in Biotechnology.

Current Evidence

BullishFTRE is in a bullish AIQ regime; Value is the strongest visible factor at 93/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is FTRE Bullish or Bearish Right Now?

FTRE currently has a bullish overall setup. Value is the strongest factor at 93/100, while Risk Resilience is weakest at 41/100. The current evidence suggests a constructive setup.

Bull Case
  • - Quality is supportive at 65/100.
  • - Momentum is constructive at 88/100.
  • - Analyst target implies +22.52% upside from the latest quote.
Bear Case
  • - Risk Resilience is weak at 41/100.
  • - Technical consensus has more sell votes than buy votes (31 vs 12).

Current Consensus

FTRE's Technical Analysis Consensus is currently Sell, with 12 buy, 3 neutral, and 31 sell votes. FTRE's 14-day RSI is 43.47, which places the stock in a weaker momentum range. FTRE's beta is 1.62, indicating greater market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in FTRE?

The largest recent change in FTRE is AIQ Score moving up by 1.0 points over the available 7-day comparison window. Value remains the strongest visible factor.

AIQ Score
+1.0
Momentum
+1.0
Quality
+0.0
Risk
+1.0

What Would Change the FTRE Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

FTRE Decision Framework

Public evidence layers, setup checks, and risk context for Fortrea Holdings Inc..

Fortrea Holdings Inc. (FTRE) Stock Analysis

Fortrea Holdings Inc. has an AIQ Score of 75/100 in a Bullish regime. Value is strongest at 93/100. Beta is 1.62, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextFTRE is in a Bullish AIQ regime with score 75/100.
Signal ConflictThe primary conflict is that value leads at 93/100 while risk lags at 41/100.
Factor EvidenceMomentum 88/100 · Value 93/100 · Quality 65/100 · Risk 41/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Value is the strongest factor at 93/100.

TimingPass

Momentum is 88/100 and RSI (14) is 43.5.

Regime fitPass

FTRE is in a Bullish regime at 75/100.

Risk controlFail

Risk factor is 41/100 with beta 1.62 and annual volatility 67.32%.

ConflictWait

Current conflict: value leads at 93/100 while risk lags at 41/100.

AIQ Score
75/100
Price
$20.20
Beta
1.62
RSI (14)
43.5

FTRE Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

FTRE Fundamentals

FTRE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$691.5M
Net income
$600K
Free cash flow
$52.5M
View full FTRE fundamental analysis

FTRE Technical Analysis

FTRE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Sell
RSI 14
43.47
Price vs SMA-50
-2.71%
View full FTRE technical analysis

FTRE Stock Catalysts

Track FTRE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 25, 2027
Analyst target
$24.75
News items
0
View FTRE earnings and stock catalysts

FTRE Dividend Analysis

FTRE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View FTRE dividend history and analysis

FTRE Financial Data

FTRE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$691.5M
EPS
$0.01
Periods
8
View FTRE financials

FTRE Risk Analysis

FTRE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.62
Risk score
41/100
1Y volatility
67.32%
View FTRE risk analysis

FTRE Stock News

FTRE stock news, market tone, recent headlines, and catalyst context.

News items
0
Updated
—
Sentiment
—
Read FTRE stock news

FTRE vs Biotechnology Peers

Current peer cohort: FTRE · GMAB · HALO · HRMY · IDYA. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
FTRE
Current stock
75/10093/10088/10041/1001.2967.32%Current
GMAB
Genmab A/S
77/10071/10094/10058/1001.2945.85%FTRE vs GMAB
HALO
Halozyme Therapeutics, Inc.
78/10076/10084/10063/1000.9541.04%FTRE vs HALO
HRMY
Harmony Biosciences Holdings, Inc.
73/10089/10066/10063/1000.0740.59%FTRE vs HRMY
IDYA
IDEAYA Biosciences, Inc.
54/10039/10063/10061/1000.1444.94%FTRE vs IDYA
Pairwise Compare links: GMAB · HALO · HRMY · IDYAFTRE vs GMABFTRE vs HALOFTRE vs HRMYFTRE vs IDYACompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a FTRE stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for FTRE: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-26.8
As of Nov 13, 2026
Revenue growth
-1.40%
Gross margin
18.54%
Current debt / equity
2.1
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$691.5M
Quarter net income
$600K
Quarter free cash flow
$52.5M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Bearish
RSI 14
43.47
MACD
-0.2

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
41/100
Beta
1.62
Annual volatility
67.32%
Max drawdown
-51.79%

FTRE Stock FAQ

What is FTRE stock price today?

Fortrea Holdings Inc.'s current stock price is $20.20. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is FTRE bullish or bearish right now?

FTRE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is FTRE's market cap?

FTRE's market cap is $1.93B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is FTRE's current P/E ratio?

FTRE's current P/E ratio is -26.8 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is FTRE's RSI?

FTRE's 14-day RSI is 43.47 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is FTRE above its 50-day and 200-day moving averages?

FTRE is -2.71% from its 50-day SMA and 27.03% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is FTRE's next earnings date?

FTRE's next earnings date is currently listed as Feb 25, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does FTRE pay a dividend?

FTRE's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.